PRKAR1A and bone neoplasm: We previously reported that approximately 80% of Prkar1a+/− mice develop osteoblastic bone tumors by one year of age and primary cultures of tumoral bones showed increased PKA activity and decreased osteoblastic differentiation compared to cells isolated from control animals [23].